R-bendamustine in the treatment of nodular lymphocyte predominant Hodgkin lymphoma-An extended follow-up

Br J Haematol. 2023 Aug;202(4):e24-e26. doi: 10.1111/bjh.18896. Epub 2023 Jun 6.

Tero Vuolio^{1

2}, Outi Kuittinen^{2

3

4}, Juha P Väyrynen^{5

6}, Hanna-Riikka Teppo^{5

6}, Roosa E I Prusila⁷, Maria Rämet⁸, Hanne Kuitunen⁹, Timo Paloneva¹⁰, Milla E L Kuusisto^{1

2

6

8}

¹ University of Oulu and Oulu University Hospital, Oulu, Finland.
² Faculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
³ Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.
⁴ Kuopio University Hospital Cancer Center, Kuopio, Finland.
⁵ Department of Pathology, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.
⁶ Translational Medicine Research Unit, University of Oulu, Oulu, Finland.
⁷ Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland.
⁸ Länsi-Pohja Central Hospital, Kemi, Finland.
⁹ Cancer Center, Oulu University Hospital, Oulu, Finland.
¹⁰ Central Ostrobothnian Central Hospital, Kokkola, Finland.

No abstract available

Publication types